Cartesian Therapeutics, Inc.
RNAC • NASDAQ
Cartesian Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carsten Brunn, with a market cap of $155.1M.
CEOCarsten Brunn
Next Earnings
Upcoming earnings announcement for Cartesian Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.76
Revenue Estimate
$261.9K
Earnings History
Past 12 earnings reports for Cartesian Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$1.39Est: -$0.80 | -73.7% | $947.0KEst: $212.1K | +346.4% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$1.38Est: -$0.70 | -97.1% | $452.0KEst: $226.5K | +99.5% | 10-Q |
| Aug 7, 2025 | Q2 2025 | $0.50Est: -$0.69 | +172.5% | $298.0KEst: $787.5K | -62.2% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.68Est: -$0.61 | -11.5% | $1.1MEst: $500.0K | +120.0% | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.40Est: -$0.83 | +51.8% | -$759.0KEst: $100.0K | -859.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$1.13Est: -$0.73 | -54.8% | $387.0KEst: $2.5M | -84.8% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.54Est: -$1.19 | +145.4% | $33.4MEst: $1.8M | +1727.6% | 10-Q |
| May 8, 2024 | Q1 2024 | -$10.50Est: -$0.88 | -1093.2% | $5.8MEst: $1.3M | +367.2% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$41.70Est: -$0.90 | -4533.3% | $8.3MEst: $5.9M | +40.8% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$1.80Est: -$1.80 | 0.0% | $6.6MEst: $11.0M | -40.6% | — |
| Aug 17, 2023 | Q2 2023 | -$0.07Est: -$0.08 | +12.5% | $5.2MEst: $11.1M | -52.7% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.14Est: -$0.09 | -55.6% | $5.9MEst: $11.8M | -49.8% | — |